Journal: Medicina
Article Title: The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials
doi: 10.3390/medicina61020278
Figure Lengend Snippet: Psychedelic-Assisted Therapies for Substance Use Disorders and Behavioral Addictions—Key Studies and Findings.
Article Snippet: A. Garcia-Romeu (USA) [ ] , Smoking biomarkers, TLFB, QSU, SASE, HRS, SOCQ, Mysticism scale , Johns Hopkins University , Psilocybin treatment resulted in significant long-term smoking cessation success , Two to three psilocybin sessions (20 mg/70 kg and 30 mg/70 kg), integrated with 15 weeks of CBT and mindfulness-based techniques for smoking cessation.
Techniques: Drug discovery, Clinical Proteomics, Concentration Assay, Transformation Assay